Epidemiological and clinical features of Spanish patients with Crohn's disease

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 10, 1999, Pages 1121-1127

  Juan, Joan ^a  

^a Nuc Med Dept   (Spain)

Author keywords

Crohn's disease; Cross sectional studies; Drug utilization; Epidemiology; Hospitalization

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; ANTIDIARRHEAL AGENT; CIPROFLOXACIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METRONIDAZOLE;

ADULT; ANUS; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; COLON; COMPLICATION; CROHN DISEASE; DIARRHEA; DISEASE ACTIVITY; DRUG UTILIZATION; ENTERITIS; FAMILY HISTORY; FEMALE; FISTULA; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; ILEUM; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; SMOKING; SPAIN; SYMPTOM;

EID: 0033364375     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199910000-00008     Document Type: Article

References (32)

1. 1 Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 1996; 39:690-697.
2. 2 Probert CSJ, Jayanthi V, Hughes AO, Thompson JR, Wicks ACB, Mayberry JF. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and South Asians in Leicestershire. Gut 1993; 34:1547-1551.
3. 3 Kyle J. Crohn's disease in the northeastern and northern isles of Scotland: an epidemiological review. Gastroenterology 1992; 103:392-399.
4. 4 Trallori G, Palli D, Saieva C, Bardazzi G, Bonamoni AG, d'Albasio G, et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol 1996; 9:892-899.
5. 5 Lindgren A, Wallerstedt S, Olsson R. Prevalence of Crohn's disease and simultaneous occurrence of extraintestinal complications and cancer. An epidemiologic study in adults. Scand J Gastroenterol 1996; 1:74-78
6. 6 Maté-Jimenez J, Muñoz S, Vicent D, Pajares JM. Incidence and prevalence of ulcerative colitis and Crohn's disease in urban and rural areas of Spain from 1981 to 1988. J Clin Gastroenterol 1994; 18:27-31.
7. 7 Martinez-Salmeron JF, Rodrigo M, de Teresa J, Nogueras F, Garcia-Montero M, de Sola C, et al. Epidemiology of inflammatory bowel disease in the province of Granada, Spain: a retrospective study from 1979 to 1988. Gut 1993; 34:1207-1209.
8. 8 Ruiz Ochoa V, Butrón M, Cueto M, Pereira S, Rodriguez D, Clofent J, et al. Epidemiology of IBD in Vigo health area, Spain. In: Inflammatory Bowel Diseases. New Insights into Mechanisms of Inflammation and Challenges in Diagnosis and Treatment. Monteiro E, Tavarela Veloso F (editors). London: Kluwer Academic Publishers; 1995. pp. 18-29.
9. 9 Solà R, Garcia-Pugés A, Monés J, Badosa C, Badosa J, Casellas F, et al. Enfermedad inflamatoria crónica intestinal en Cataluña. Rev Esp Enf Digest 1992; 81:7-14.
10. 10 Pajares J, Rodriguez S, Maté J. Prevalencia de la enfermedad de Crohn en la zona central de España (ambas Castillas, La Mancha, Cantabria y Rioja). Estudio epidemiológico cooperativo de la Asociación Castellana de Aparato Digestivo (ACAD). Rev Esp Enferm Apar Dig 1987; 71:313-317.
11. 11 Martinez G, Fernandez Y, Rodrigo L, Martinez E. Estudio epidemiológico de la enfermedad de Crohn en la región asturiana. Rev Esp Enferm Apar Dig 1983; 63:534-541.
12. 12 Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. Gastroenterology 1976; 70:439-444.
13. 13 Drossman D, Leserman J, Mitchell, M, Li Z, Zagami E, Patrick D. Health status and health care use in persons with inflammatory bowel disease. A national sample. Dig Dis Sci 1991; 36:1746-1755.
14. 14 Persson PG, Bernell O, Leijonmarck CE, Farahmand BY, Hellers G, Ahlbom A. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 1996; 110:1339-1345.
15. 15 Lapidus A, Bernell O , Hellers G, Persson PG, Löfberg R. Incidence of Crohn's disease in Stockholm county 1955-1989. Gut 1997; 41:480-486.
16. 16 Rose JDR, Roberts GM, Williams G, Mayberry JF, Rhodes J. Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut 1988; 29:346-351.
17. 17 Alonso P, Ulla M, Soriano M, Aquise M, Del Villar V. Enfermedad inflamatoria intestinal en la provincia de Soria. Estudio clinico y epidemiológico retrospectivo del periodo 1981-1990. Rev Esp Enf Digest 1992; 82:87-91.
18. 18 Cebolla J, López J, Sopeña F, Nerin JM, Gomollón F, Sainz R. Aspectos epidemiológicos de la enfermedad de Crohn en Zaragoza. Rev Esp Enf Digest 1991; 79:186-189.
19. 19 Nos P, Arguello L, Hoyos M, Ramirez JJ, Hinojosa J, Moles JR, et al. Afectación familiar en la enfermedad inflamatoria crónica intestinal. Diferencias entre grupos de pacientes con y sin historia familiar. Rev Esp Enferm Dig 1996; 88:470-474.
20. 20 Koutroubakis I, Peña A. Genetics of inflammatory bowel disease. In: Inflammatory Bowel Diseases. Allan R, Rhodes J, Hanauer S, Keighley M, Alexander-Williams J, Fazio V (editors). Edinburgh: Churchill Livingstone; 1997. pp. 13-26.
21. 21 Polito II J, Childs B, Mellits D, Tokayer A, Harris M, Bayless T. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996; 111:580-586.
22. 22 Tobacco or Health. A Global Status Report. Geneva: World Health Organization; 1997.
23. 23 Thomas GAO, Rhodes J, Green JT. Inflammatory bowel disease and smoking. A review. Am J Gastroenterol 1998; 93:144-149.
24. 24 Rhodes J, Thomas GAO. Smoking: good or bad for inflammatory bowel disease? Gastroenterology 1994; 106:807-809.
25. 25 Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996; 110:424-431.
26. 26 Langman MJS. Epidemiological overview of inflammatory bowel disease. In: Inflammatory Bowel Diseases. Allan R, Rhodes J, Hanauer S, Keighley M, Alexander-Williams J, Fazio V (editors). Edinburgh: Churchill Livingstone; 1997. pp. 35-39.
27. 27 Lennard-Jones J, Shivananda S and the EC-IBD Study Group. Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. Eur J Gastroenterol Hepatol 1997; 9:353-359.
28. 28 McKee RF, Keenan RA. Perianal Crohn's disease. Is it all bad news? Dis Colon Rectum 1996; 39:136-142.
29. 29 Plevy SE, Targan SR. Specific management of Crohn's disease. In: Inflammatory Bowel Disease. From Bench to Bedside. Targan SR, Shanahan F (editors). Baltimore: Williams & Wilkins; 1994. pp. 582-609.
30. 30 Whelan G, Farmer RG, Fazio VW, Goormastic M. Recurrence after surgery in Crohn's disease: relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology 1985; 88:1826-1833.
31. 31 Blomqvist P, Ekbom A. Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol 1997; 32:1134-1139.
32. 32 Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine and methotrexate. Am J Gastroenterol 1996; 91:423-433.